These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 30727971

  • 1. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
    Sauboin C, Holl K, Bonanni P, Gershon AA, Benninghoff B, Carryn S, Burgess MA, Wutzler P.
    BMC Infect Dis; 2019 Feb 06; 19(1):126. PubMed ID: 30727971
    [Abstract] [Full Text] [Related]

  • 2. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
    Ouwens MJ, Littlewood KJ, Sauboin C, Téhard B, Denis F, Boëlle PY, Alain S.
    Clin Ther; 2015 Apr 01; 37(4):816-829.e10. PubMed ID: 25726457
    [Abstract] [Full Text] [Related]

  • 3. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S, Guzzetta G, Flem E, Mirinaviciute G, Scalia Tomba G, Manfredi P.
    Vaccine; 2018 Feb 14; 36(8):1116-1125. PubMed ID: 29366704
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
    van Lier A, Lugnér A, Opstelten W, Jochemsen P, Wallinga J, Schellevis F, Sanders E, de Melker H, van Boven M.
    EBioMedicine; 2015 Oct 14; 2(10):1494-9. PubMed ID: 26629544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vaccination to prevent varicella: Goldman and King's response to Myers' interpretation of Varicella Active Surveillance Project data.
    Goldman GS, King PG.
    Hum Exp Toxicol; 2014 Aug 14; 33(8):886-93. PubMed ID: 24275643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM, Eisenberg MC, Woods RJ, Martinez ME.
    BMC Med; 2022 Oct 08; 20(1):387. PubMed ID: 36209074
    [Abstract] [Full Text] [Related]

  • 10. The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom.
    van Hoek AJ, Melegaro A, Gay N, Bilcke J, Edmunds WJ.
    Vaccine; 2012 Feb 01; 30(6):1225-34. PubMed ID: 22119592
    [Abstract] [Full Text] [Related]

  • 11. The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study.
    Melegaro A, Marziano V, Del Fava E, Poletti P, Tirani M, Rizzo C, Merler S.
    BMC Med; 2018 Jul 17; 16(1):117. PubMed ID: 30012132
    [Abstract] [Full Text] [Related]

  • 12. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS.
    Int J Toxicol; 2005 Jul 17; 24(4):205-13. PubMed ID: 16126614
    [Abstract] [Full Text] [Related]

  • 13. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
    Harpaz R, van Hoek AJ.
    J Infect Dis; 2018 Sep 22; 218(suppl_2):S57-S62. PubMed ID: 30247602
    [Abstract] [Full Text] [Related]

  • 14. Herpes zoster in the context of varicella vaccination - An equation with several variables.
    Wutzler P, Casabona G, Cnops J, Akpo EIH, Safadi MAP.
    Vaccine; 2018 Nov 12; 36(46):7072-7082. PubMed ID: 30309745
    [Abstract] [Full Text] [Related]

  • 15. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N.
    Vaccine; 2011 Mar 16; 29(13):2411-20. PubMed ID: 21277405
    [Abstract] [Full Text] [Related]

  • 16. The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Suh J, Lee T, Choi JK, Lee J, Park SH.
    Vaccine; 2021 Apr 28; 39(18):2575-2583. PubMed ID: 33814230
    [Abstract] [Full Text] [Related]

  • 17. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
    Goldman GS.
    Vaccine; 2005 May 09; 23(25):3349-55. PubMed ID: 15837242
    [Abstract] [Full Text] [Related]

  • 18. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT.
    BMC Med; 2018 Jan 09; 16(1):3. PubMed ID: 29316913
    [Abstract] [Full Text] [Related]

  • 19. Understanding the role of exogenous boosting in modeling varicella vaccination.
    Talbird SE, La EM, Mauskopf J, Altland A, Daniels V, Wolfson LJ.
    Expert Rev Vaccines; 2018 Nov 09; 17(11):1021-1035. PubMed ID: 30354696
    [Abstract] [Full Text] [Related]

  • 20. Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study.
    Betta M, Landi A, Manfredi P, Laurino M.
    Med Biol Eng Comput; 2019 May 09; 57(5):1121-1132. PubMed ID: 30652233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.